PharVision Advisers’s FirstCash FCFS Stock Holding History

PharVision Advisers’s Portfolio FCFS Stock Details FCFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,393	Closed	-$248K	–	349
2024 Q4	$248K	Buy	+2,393	New	+$258K	0.21%	226

Other funds holding FCFS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

PharVision Advisers's FCFS Position: Q1 2025 in Review

PharVision Advisers sold out of FirstCash (FCFS) in Q1 2025, closing a stake of 2,393 shares — an estimated $248K sold.

PharVision Advisers first reported a position in FCFS in Q4 2024 and held it in 1 quarter. The position peaked at $248K in Q4 2024. 353 funds tracked by Wall St. Rank hold FCFS as of Q1 2025.

PharVision Advisers reported no remaining FirstCash position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 2,393 FirstCash shares in Q1 2025, an estimated $248K.
PharVision Advisers first reported a position in FirstCash in Q4 2024 and held it in 1 quarter.
PharVision Advisers's FirstCash position peaked at $248K in Q4 2024.
353 funds tracked by Wall St. Rank held FirstCash as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.